May 15th, 2026
11:00 AM - 2:00 PM PST

This annual online event, produced and moderated by the End Brain Cancer Initiative (EBCI), is designed specifically for patients, caregivers, and healthcare providers to hear directly from top specialists about glioblastoma (GBM) and recurrent glioblastoma (rGBM) treatment options, including clinical trials, devices, diagnostics, and more.

The 2026 Know All Your GBM/rGBM Treatment Options event was recorded and an edited version is available below. For your convenience, individual presentations are also available further down this page.

2026 Full Webinar

Join to Hear the Announcement of the 2026 National HOPE Award Winner!

Each May, the EndBrainCancer Initiative, in Partnership with Novocure, has presented the HOPE Award to brain cancer patients who deeply inspire us with their courage and story. We established this award to highlight exceptional people who have done exceptional things during their brain cancer journey all while inspiring others.

2026 Event Sponsorship Opportunities

Interested in sponsoring the End Brain Cancer Initiative's 2026 Know All Your Treatment Options (KAYTO) event/webinar? This annual online event allows members of the brain tumor/brain cancer community to hear directly from top experts in the neuro-oncology field about brain cancer new research, clinical trials, treatments, devices, advanced diagnostics, personal introductions to these researchers, specialists, and more. Your support will directly have a positive impact on the distribution, reach and success of this event, as well as the awareness and outreach leading up to the event and the lasting patient disease educational videos that are created from this online webinar from each presentation. Please fill out the form below to request more information about sponsorship tiers and sponsorship benefits.

Eric T. Wong, MD

Professor of Neurology, Medicine, Neurosurgery and Radiation Oncology & Director of Medical Neuro-Oncology - Brown University Health Cancer Institute

"How to Become Clinical Trial Ready, Using the Optune Gio Device for GBM/rGBM & the FORTE Clinical Trial”

Eric T. Wong, MD, an authority on advanced treatments for glioblastoma, is director of the medical neuro-oncology service at the Brown University Health Cancer Institute. He is a professor of neurology, medicine, neurosurgery and radiation oncology at The Warren Alpert Medical School of Brown University.

Dr. Wong brings extensive knowledge and research experience that focuses on device and drug therapies for primary malignant brain tumors, imaging of neurologic malignancies, and management of leptomeningeal metastases in the central nervous system. In the past two decades, his work has led to the development of innovative cancer treatment technologies, and simultaneously transformed the management of brain cancer by oncologists.

Dr. Wong earned a bachelor of science degree in electrical engineering from the University of Pennsylvania and a doctor of medicine degree from Rutgers Robert Wood Johnson Medical School. He pursued an internship in internal medicine at the Rutgers New Jersey Medical School, followed by a residency in neurology at Barnes Jewish Hospital, Washington University School of Medicine as well as fellowships in neuro-oncology at Memorial-Sloan Kettering Cancer Center and the University of Texas MD Anderson Cancer Center.

Dr. Wong's presentation is available below.

Cameron Lilly, PhD

Medical Science Liaison - Belay Diagnostics

"CSF Liquid Biopsy for GBM/rGBM”

Cameron L. Lilly, PhD earned his PhD In molecular virology and was then introduced to the challenges of rare diseases and cancers during his post-doctoral research on oncolytic virotherapy. From his post-doc, he entered industry to leverage his passion for strong science and science communication in a sales role at Cell Signaling Technology, where he developed his commercial acumen. From there, the clear patient need lead to him joining the liquid biopsy space first as a Scientific Affair Liaison then as an MSL for cell-based and cell-free technologies for monitoring and characterizing cancer. He brings his 5+ years of experience in liquid biopsy and interfacing in the health care space with HCPs and KOLs to the team at Belay, where he has joined as MSL to bring his passion for cutting edge and patient-centered medical science to the challenging field of CNS tumors.

Dr. Lilly's presentation is available below.

Michael C. Magnifico, MD

Medical Advisor - Pacific Marine Biotech

"A Phase 2 Clinical Trial of Immune12 (ANZCTR)"

Michael Magnifico, MD, holds three board certifications: internal medicine, medical oncology and hematology. During his decades of clinical practice, he directly cared for patients throughout northwest Connecticut, notably at Sharon Hospital, Charlotte Hungerford Hospital and New Milford Hospital; and served as medical director of the VNA Hospice in Torrington for 30 years.

Dr. Magnifico received his baccalaureate of medical sciences from Dartmouth Medical School and obtained his medical degree from Columbia University College of Physicians and Surgeons. His residencies in medicine and anatomic pathology were at Columbia Presbyterian Medical Center, and he completed his fellowships in medical oncology and hematology at the Yale School of Medicine.

Dr. Magnifico's presentation is available below.

Shreya Prakash

"EBCI Patient/Caregiver and Clinical Trial Navigation Services"

In this segment of the End Brain Cancer Initiative’s “Know All Your GBM Treatment Options” webinar, Clinical Research Coordinator/Patient Navigator Shreya Prakash will share how EBCI supports patients and caregivers through free one-on-one guidance in their "DIRECT CONNECT" Program. She will introduce EBCI’s Patient Resource Center, which offers fact sheets on immunotherapy side effects, clinical trials, questions to ask your care team, practical tips for using the Optune Gio device, and more. Shreya will also explain how to access these resources online and how to request help by filling out a Patient Inquiry Form. Support is available by phone, email, text, Zoom, or in-person at EBCI’s Redmond, WA office. For support, email Shreya@EndBrainCancer.org or call/text 425-436-8688.

Ms. Prakash's presentation is available below.

The 2026 National HOPE Award winner was announced during this event. The National HOPE Award is an annual Patient Disease Education, Awareness & Outreach Initiative honoring glioblastoma (GBM) patients who inspire others through their courage and resilience. Supported by Novocure, this program spotlights patient stories that educate, empower, and bring HOPE to the brain tumor community. 

The End Brain Cancer Initiative is excited to announce its 2026 recipient of the National HOPE Award: Becky Moroney. Becky was diagnosed with glioblastoma (GBM), an aggressive form of brain cancer, in 2021. 

Her tumor was deemed inoperable, but thanks to the care provided by her loving sister and an excellent neurooncologist, who introduced her to the Optune GIO device, Becky is not just surviving but thriving.


The award presentation may be watched below.

2026 HOPE Award Recipient Becky Moroney